首页> 外国专利> Process for the preparation of enteric alginate microcapsules by ionic gelation containing diclofenac or one of its salts and multiparticulate pharmaceutical composition containing them

Process for the preparation of enteric alginate microcapsules by ionic gelation containing diclofenac or one of its salts and multiparticulate pharmaceutical composition containing them

机译:通过离子凝胶法制备含有双氯芬酸或其盐之一的肠藻酸盐微胶囊的方法以及含有它们的多颗粒药物组合物

摘要

Process for preparing enteric microcapsules of calcium alginate of homogeneous composition containing diclofenac or one of its salts, characterized in that it comprises the following steps: A) preparing a solution of an alginate salt, selected from sodium, potassium or ammonium alginate , in water-ethanol and dissolve under stirring diclofenac or one of its salts in the presence of a surfactant selected from the group consisting of sorbitan monostearate, sorbitan monooleate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monolaurate and sodium bicarbonate, sodium bicarbonate a temperature below 60 ° C; B) incorporate the solution obtained in A) into a solution of calcium chloride controlling the temperature below 60 ° C, during the whole process; C) resuspend the microcapsules formed and isolated without prior drying in a solution of said alginate salt, with a concentration between 0.05% and 0.1%, with stirring for 30 to 120 minutes at room temperature; D) filtration, drying and sieving successively by 1000 and 250 micron meshes, selecting for the preparation of the pharmaceutical composition only the fraction of microcapsules obtained and of size between both meshes, in which the microcapsules obtained and selected have a active substance content exceeding 55%; E) and optionally, convert the microcapsules thus obtained into extended release microcapsules.
机译:制备含有双氯芬酸或其盐之一的均质组合物的藻酸钙肠溶微胶囊的方法,其特征在于它包括以下步骤:A)制备选自海藻酸钠,钾或铵的藻酸盐溶液,乙醇并在双氯芬酸或其一种盐在搅拌下在表面活性剂存在下溶解,该表面活性剂选自脱水山梨醇单硬脂酸酯,脱水山梨醇单油酸酯,聚氧乙烯脱水山梨醇单硬脂酸酯,聚氧乙烯山梨醇单油酸酯,聚氧乙烯脱水山梨醇单月桂酸酯和碳酸氢钠,碳酸氢钠温度低于60 °C; B)在整个过程中,将A)中获得的溶液加入控制温度低于60℃的氯化钙溶液中; C)将所形成和分离的微胶囊重悬,而无需事先干燥,将其在浓度为0.05%至0.1%的所述海藻酸盐溶液中,在室温下搅拌30至120分钟; D)依次通过1000和250微米筛孔过滤,干燥和筛分,仅选择所获得的微胶囊的部分和两个筛孔之间的大小的部分用于制备药物组合物,其中所获得和选择的微胶囊的活性物质含量超过55 %; E)并任选地,将由此获得的微胶囊转化成缓释微胶囊。

著录项

  • 公开/公告号ES2584403T3

    专利类型

  • 公开/公告日2016-09-27

    原文格式PDF

  • 申请/专利权人 EASTBRAND HOLDING GMBH;LABORATORIOS BAGÓ S.A.;

    申请/专利号ES20120709640T

  • 发明设计人 ATILIO LOS MARIO;

    申请日2012-03-20

  • 分类号A61K9;A61K9/10;A61K9/14;A61K9/16;A61K9/20;A61K9/50;A61K31/196;A61K31/4439;A61K47/36;

  • 国家 ES

  • 入库时间 2022-08-21 14:22:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号